Figure 1.
Total and free clearance (CL) per kg lean body weight (LBW) for (R)- and (S)-warfarin vs. age in 72 patients on long term warfarin therapy. For (S)-warfarin; CYP2C9 genotype *1/*1 (•),*1/*2 or *1/*3 (○) and *2/*3 (▾)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.